Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Vaccine

• Publication date

  2008-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2007.11.082PMID 18191005PMCID PMC2246307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospects for a dengue virus vaccine

  2007cited by this paper
• Flaviviridae :T he Viruses and Their Replication

  2007cited by this paper
• The Live Attenuated Dengue Serotype 1 Vaccine rDEN1Δ30 is Safe and Highly Immunogenic in Healthy Adult Volunteers

  2006cited by this paper
• rDEN2/4Δ30(ME), a Live Attenuated Chimeric Dengue Serotype 2 Vaccine, is Safe and Highly Immunogenic in Healthy Dengue-Naïve Adults

  2006cited by this paper
• Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics

  2006cited by this paper
• Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

  2006cited by this paper
• Rational Design of Genetically Stable, Live-Attenuated Poliovirus Vaccines of All Three Serotypes: Relevance to Poliomyelitis Eradication

  2006cited by this paper
• Secondary structure of dengue virus type 4 3' untranslated region: impact of deletion and substitution mutations.

  2006cited by this paper
• Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication.

  2005influential reference
• Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys

  2005cited by this paper
• rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers

  2005cited by this paper
• Recombination and flavivirus vaccines: a commentary.

  2005cited by this paper
• rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers.

  2005cited by this paper
• Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

  2004cited by this paper
• 5′- and 3′-noncoding regions in flavivirus RNA

  2004cited by this paper
• Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

  2004influential reference
• Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

  2004cited by this paper
• Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.

  2004cited by this paper
• Mfold web server for nucleic acid folding and hybridization prediction

  2003cited by this paper
• Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

  2003cited by this paper
• A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

  2003cited by this paper
• Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.

  2003cited by this paper
• Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.

  2003cited by this paper
• A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4.

  2003cited by this paper
• Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

  2002cited by this paper
• Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in Monkeys

  2002cited by this paper
• Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.

  2002cited by this paper
• Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

  2001cited by this paper
• Genetic variation in the 3' non-coding region of dengue viruses.

  2001cited by this paper
• A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.

  2001influential reference
• Sequence comparison and secondary structure analysis of the 3' noncoding region of flavivirus genomes reveals multiple pseudoknots.

  2001cited by this paper
• Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

  2001influential reference
• Dengue haemorrhagic fever: diagnosis, treatment, prevention and control

  1999cited by this paper
• Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure.

  1999cited by this paper
• Impact of dengue/dengue hemorrhagic fever on the developing world.

  1999cited by this paper
• Identification of Specific Nucleotide Sequences within the Conserved 3′-SL in the Dengue Type 2 Virus Genome Required for Replication

  1998cited by this paper
• The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future.

  1998cited by this paper
• Dengue and Dengue Hemorrhagic Fever

  1998cited by this paper
• The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future.

  1998cited by this paper
• Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences.

  1997cited by this paper
• Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys

  1996cited by this paper
• Epidemic dengue 3 in central Java, associated with low viremia in man.

  1981cited by this paper

• From promise to pitfalls: immunological lessons from dengue vaccines and their implications.

  2026cites this paper
• E protein inhibitors and host-directed therapies in dengue virus infection: perspectives on combination and complementary antiviral strategies

  2025cites this paper
• Knowledge-based mitigation of the environmental risk of Orthoflavivirus live-attenuated vaccines by targeting viral encoded determinants for the mosquito attenuated phenotype.

  2025cites this paper
• Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue

  2025cites this paper
• DENV-2 3′UTR dumbbell structure is a critical factor for viral infection and dissemination in Aedes mosquito

  2025cites this paper
• Recent Vaccines against Emerging and Tropical Infectious Diseases

  2024cites this paper
• Subgenomic flavivirus RNA as key target for live-attenuated vaccine development

  2024cites this paper
• Complexities of Dengue Fever: Pathogenesis, Clinical Features and Management Strategies

  2024cites this paper
• Current status of the development of dengue vaccines

  2024cites this paper
• Association of Dengue Virus Serotypes 1&2 with Severe Dengue Having Deletions in Their 3′Untranslated Regions (3′UTRs)

  2023cites this paper
• Establishment of quantitative and recovery method for detection of dengue virus in wastewater with noncognate spike control.

  2023cites this paper
• Zika virus dumbbell-1 structure is critical for sfRNA presence and cytopathic effect during infection

  2023cites this paper
• NS1 Protein N-Linked Glycosylation Site Affects the Virulence and Pathogenesis of Dengue Virus

  2023cites this paper
• Novel approaches for the rapid development of rationally designed arbovirus vaccines

  2023cites this paper
• Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine

  2023cites this paper
• An effective live-attenuated Zika vaccine candidate with a modified 5′ untranslated region

  2023cites this paper
• Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial

  2022cites this paper
• Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines

  2022cites this paper
• Stem-Loop I of the Tembusu Virus 3′-Untranslated Region Is Responsible for Viral Host-Specific Adaptation and the Pathogenicity of the Virus in Mice

  2022cites this paper
• Interactions of host miRNAs in the flavivirus 3´UTR genome: From bioinformatics predictions to practical approaches

  2022cites this paper
• Dengue Vaccines: An Update

  2022cites this paper
• An Evaluation of Different Types of Peptone as Partial Substitutes for Animal-derived Serum in Vero Cell Culture

  2022cites this paper
• Sequence duplication in 3′ UTR modulates virus replication and virulence of Japanese encephalitis virus

  2021cites this paper
• NS5-independent Ablation of STAT2 by Zika virus to antagonize interferon signalling

  2021cites this paper
• Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines

  2021cites this paper
• Evaluation in Swine of a Recombinant African Swine Fever Virus Lacking the MGF-360-1L Gene

  2020cites this paper
• Erratum: Ramirez-Medina, E.; et al. Evaluation in Swine of a Recombinant African Swine Fever Virus Lacking the MGF-360-1L Gene. Viruses 2020, 12, 1193

  2020cites this paper
• Dengue Vaccines: An Update

  2020cites this paper
• Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade

  2020cites this paper
• Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques

  2020cites this paper
• Advancements in developing an effective and preventive dengue vaccine

  2020cites this paper
• Anti-dengue Vaccines: From Development to Clinical Trials

  2020cites this paper
• Disruption of Zika Virus xrRNA1-Dependent sfRNA1 Production Results in Tissue-Specific Attenuated Viral Replication

  2020cites this paper
• Different Degrees of 5'-to-3' DAR Interactions Modulate Zika Virus Genome Cyclization and Host-Specific Replication

  2019cites this paper
• Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines

  2019cites this paper
• The Interplay between Dengue Virus and the Human Innate Immune System: A Game of Hide and Seek

  2019cites this paper
• Dengue viruses and promising envelope protein domain III-based vaccines

  2018cites this paper
• What Does the Future Hold for Yellow Fever Virus? (I)

  2018cites this paper
• Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Δ30 increases viral susceptibility to type I interferon.

  2018cites this paper
• A Single Mutation at Position 156 in the Envelope Protein of Tembusu Virus Is Responsible for Virus Tissue Tropism and Transmissibility in Ducks

  2018cites this paper
• What Does the Future Hold for Yellow Fever Virus? (II)

  2018cites this paper
• Translation-mediated stress responses : mining of ribosome profiling data

  2017cites this paper
• Zika Virus Exhibits Lineage-Specific Phenotypes in Cell Culture, in Aedes aegypti Mosquitoes, and in an Embryo Model

  2017cites this paper
• New reverse genetics and transfection methods to rescue arboviruses in mosquito cells

  2017cites this paper
• Possible Roles of New Mutations Shared by Asian and American Zika Viruses

  2017cites this paper
• Epitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal Antibodies

  2017cites this paper
• The 5′ and 3′ Untranslated Regions of the Flaviviral Genome

  2017cites this paper
• Cell culture-based viral vaccines: current status and future prospects

  2016cites this paper
• Dengue vaccines: Are they safe for travelers?

  2016cites this paper
• RNA Structure Duplications and Flavivirus Host Adaptation.

  2016cites this paper
• Ecuador Paraiso Escondido Virus, a New Flavivirus Isolated from New World Sand Flies in Ecuador, Is the First Representative of a Novel Clade in the Genus Flavivirus

  2015cites this paper
• Repertoire of virus-derived small RNAs produced by mosquito and mammalian cells in response to dengue virus infection.

  2015cites this paper
• Dengue vaccines: challenges, development, current status and prospects.

  2015cites this paper
• Functions of the 3' and 5' genome RNA regions of members of the genus Flavivirus.

  2015cites this paper
• An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques

  2015cites this paper
• Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine.

  2015cites this paper
• Recent progress in dengue vaccine development

  2014cites this paper
• Substitution of NS5 N-terminal Domain of Dengue Virus Type 2 RNA with Type 4 Domain Caused Impaired Replication and Emergence of Adaptive Mutants with Enhanced Fitness*

  2014cites this paper
• Flavivirus reverse genetic systems, construction techniques and applications: A historical perspective

  2014cites this paper
• Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development

  2014cites this paper
• Endothelial cells in dengue hemorrhagic fever.

  2014cites this paper
• Medical Biotechnology Dengue: Possible strategies for molecular vaccine production

  2014cites this paper
• Vaccine Development against Dengue, a Viral Disease of Increasing Significance to Global Public Health

  2014cites this paper
• Flaviviral RNAs: weapons and targets in the war between virus and host.

  2014cites this paper
• Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.

  2014cites this paper
• Dengue virus vaccine development.

  2014cites this paper
• Molecular Archaeology of Flaviviridae Untranslated Regions: Duplicated RNA Structures in the Replication Enhancer of Flaviviruses and Pestiviruses Emerged via Convergent Evolution

  2014cites this paper
• Editorial Vaccine Development against Dengue, a Viral Disease of Increasing Significance to Global Public Health

  2014cites this paper
• Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles.

  2013cites this paper
• Challenges in reducing dengue burden; diagnostics, control measures and vaccines

  2013cites this paper
• Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.

  2013cites this paper
• Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

  2013cites this paper
• Comparison of full-length genomics sequences between dengue virus serotype 3, parental strain, and its derivatives, and B-cell epitopes prediction from envelope region

  2013cites this paper
• Understanding the Dengue Viruses and Progress towards Their Control

  2013cites this paper
• The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.

  2013cites this paper
• Challenges in reducing dengue burden; diagnostics, control measures and

  2013cites this paper
• Using recombinant DNA technology for the development of live-attenuated dengue vaccines.

  2012cites this paper
• Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization

  2012cites this paper
• Replication of the Primary Dog Kidney-53 Dengue 2 Virus Vaccine Candidate in Aedes aegypti Is Modulated by a Mutation in the 5′ Untranslated Region and Amino Acid Substitutions in Nonstructural Proteins 1 and 3

  2011cites this paper
• Issues Related to Recent Dengue Vaccine Development

  2011cites this paper
• Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts

  2011cites this paper
• A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses

  2011cites this paper
• A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

  2011cites this paper
• Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine.

  2011cites this paper
• Immune response to dengue virus and prospects for a vaccine.

  2011cites this paper
• Review of dengue virus and the development of a vaccine.

  2011cites this paper
• Functions and requirements of conserved RNA structures in the 3’ untranslated region of Flaviviruses

  2011cites this paper
• Recombinant, Chimeric, Live, Attenuated Vaccines Against Flaviviruses and Alphaviruses

  2011cites this paper
• Nucleic Acid-Based Infectious and Pseudo-Infectious Flavivirus Vaccines

  2011cites this paper
• La dengue : un vaccin à l'horizon 2015

  2011cites this paper
• Article Title : Replication enhancer elements within the open reading frame of tick-borne encephalitis virus and their evolution within the Flavivirus genus Year of publication : 2011

  2011cites this paper
• Replication enhancer elements within the open reading frame of tick-borne encephalitis virus and their evolution within the Flavivirus genus

  2011cites this paper
• A Single Amino Acid in Nonstructural Protein NS4B Confers Virulence to Dengue Virus in AG129 Mice through Enhancement of Viral RNA Synthesis

  2011cites this paper
• Control of dengue virus translation and replication.

  2010cites this paper
• WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11-12 May 2009.

  2010cites this paper
• Targeted mutagenesis as a rational approach to dengue virus vaccine development.

  2010cites this paper
• Bioinformatics in New Generation Flavivirus Vaccines

  2010cites this paper
• Dengue vaccine candidates in development.

  2010cites this paper
• Pathogenesis and prevention of dengue virus infection: state-of-the-art

  2009cites this paper
• Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: A potential model for vaccine testing

  2009cites this paper